Ads
-
Related paper
- Treatment and prophylaxis of moderate and severe bronchopulmonary dysplasia in premature neonates
- BRONCHOPULMONARY DYSPLASIA IN EXTREMELY PREMATURE INFANTS AND VITAMIN D SUPPLY: PERINATAL FEATURES
- Antenatal and Genealogical Risk Factors for Bronchopulmonary Dysplasia and Dysplastic Dependent Pathology of Bronchopulmonary System in Children
- Determination of the Need and Assessment Algorithms of the Scope of Activity of Regional Centers for Diagnosis and Treatment of Bronchopulmonary Dysplasia
- Development of Model of Stage Health Care System for Patients with Bronchopulmonary Dysplasia. Stage I: Determining the Need for Regional Centers for Diagnosis and Treatment
- TOCILIZUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE TO SEVERE COVID-19 PNEUMONIA: A SINGLE-CENTRE EXPERIENCE
- Efficacy and tolerability of atorvastatin as add on therapy in the treatment of chronic stable (moderate-severe) asthma for a duration of 8 weeks
- Mesenchymal Stem Cells: A New Approach for Treating Bronchopulmonary Dysplasia | Biomedgrid
- Impact of Calorie Intakes on the Risk of Bronchopulmonary Dysplasia in Extremely Preterm Infants
- PROGNOSTIC AND DIAGNOSTIC SIGNIFICANCE OF THE CLARA CELL PROTEIN LEVEL IN BRONCHOPULMONARY DYSPLASIA IN PRETERM NEWBORNS